Senior Clinical Research Associate - Remote/On-Site Trials

ERGOMED; San Francisco (CA); Hybrid; USD 70,000 - 100,000; Full time

Job summary

Ergomed Group is seeking a Clinical Monitoring professional to perform on-site or remote monitoring visits, ensuring investigator sites remain qualified and capable for trial conduct across phase 2/3 studies. You will train site staff and support regulatory submissions as needed.

Join a global CRO family—Ergomed, PrimeVigilance, Prudentia, and ADAMAS—driving safety, data quality, and patient benefit in oncology and rare diseases. Travel nationally is expected.

Qualifications

• College/University degree in Life Sciences or equivalent
• Extensive on-site monitoring experience in phase 2/3 trials, ideally with complex oncology/rare disease trials
• Full working proficiency in English
• Ability to plan, multitask and work in a dynamic team environment
• Communication, collaboration, and problem-solving skills
• Ability to travel nationally

Responsibilities

• Performs on-site or remote Pre-Study, Initiation, Interim, and Close-Out monitoring visit activities to ensure facilities and staff are adequate
• Identifies investigators and verifies qualifications, resources, facilities, equipment and staff
• Trains investigational site staff as necessary
• Supports preparation of regulatory submissions when applicable
• Mentors/train junior staff and conducts co-monitoring visits to assess performance

Skills

Life sciences knowledge

Clinical monitoring

English proficiency

multitasking

Education

Bachelor's degree in Life Sciences

Job description

Ergomed Group is seeking a Clinical Monitoring professional to perform on-site or remote monitoring visits, ensuring investigator sites remain qualified and capable for trial conduct across phase 2/3 studies. You will train site staff and support regulatory submissions as needed.

Join a global CRO family—Ergomed, PrimeVigilance, Prudentia, and ADAMAS—driving safety, data quality, and patient benefit in oncology and rare diseases. Travel nationally is expected.